Trials / Completed
CompletedNCT02191384
Comparison of Orcinoside With Placebo in Treatment of MDD
Proof Of Concept Study of Orcinoside in the Treatment of Major Depressive Disorder(MDD): a Randomized, Double-Blind, Placebo-Paralleled,Dose-Finding, Multicenter Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 186 (actual)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Orcinoside Capsule in different doses are effective in the treatment of Depression. And to explore the preliminary information of safety and efficacy of Orcinoside Capsule in the Chinese Patients with Depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Orcinoside | oral, twice per day |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-03-09
- Completion
- 2016-03-09
- First posted
- 2014-07-16
- Last updated
- 2021-09-23
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02191384. Inclusion in this directory is not an endorsement.